Description
This liquid spray format supplies Bremelanotide (PT-141), a cyclic melanocortin receptor agonist derived from the alpha-MSH framework. The mucosal route supports research into centrally mediated melanocortin signaling.
Research has examined melanocortin receptor activation, behavioral response endpoints, and second-messenger signaling in rodent and cell models. The liquid spray format supports absorption and pharmacokinetic-style study designs in laboratory settings.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.